Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35


Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.).

Falendysz EA, Lopera JG, Doty JB, Nakazawa Y, Crill C, Lorenzsonn F, Kalemba LN, Ronderos MD, Mejia A, Malekani JM, Karem K, Carroll DS, Osorio JE, Rocke TE.

PLoS Negl Trop Dis. 2017 Aug 21;11(8):e0005809. doi: 10.1371/journal.pntd.0005809. eCollection 2017 Aug.


Cardiac Autoimmunity: Myocarditis.

Bracamonte-Baran W, Čiháková D.

Adv Exp Med Biol. 2017;1003:187-221. doi: 10.1007/978-3-319-57613-8_10. Review.


Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.

Churchyard G, Mlisana K, Karuna S, Williamson AL, Williamson C, Morris L, Tomaras GD, De Rosa SC, Gilbert PB, Gu N, Yu C, Mkhize NN, Hermanus T, Allen M, Pensiero M, Barnett SW, Gray G, Bekker LG, Montefiori DC, Kublin J, Corey L.

PLoS One. 2016 Sep 1;11(9):e0161753. doi: 10.1371/journal.pone.0161753. eCollection 2016.


Defending against smallpox: a focus on vaccines.

Voigt EA, Kennedy RB, Poland GA.

Expert Rev Vaccines. 2016 Sep;15(9):1197-211. doi: 10.1080/14760584.2016.1175305. Epub 2016 Apr 28. Review.


Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines.

Meseda CA, Atukorale V, Kuhn J, Schmeisser F, Weir JP.

PLoS One. 2016 Feb 19;11(2):e0149364. doi: 10.1371/journal.pone.0149364. eCollection 2016.


Adversomics: a new paradigm for vaccine safety and design.

Whitaker JA, Ovsyannikova IG, Poland GA.

Expert Rev Vaccines. 2015 Jul;14(7):935-47. doi: 10.1586/14760584.2015.1038249. Epub 2015 May 2. Review.


Cardiac safety of Modified Vaccinia Ankara for vaccination against smallpox in a young, healthy study population.

Zitzmann-Roth EM, von Sonnenburg F, de la Motte S, Arndtz-Wiedemann N, von Krempelhuber A, Uebler N, Vollmar J, Virgin G, Chaplin P.

PLoS One. 2015 Apr 16;10(4):e0122653. doi: 10.1371/journal.pone.0122653. eCollection 2015.


Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Root-Bernstein R, Fairweather D.

J Theor Biol. 2015 Jun 21;375:101-23. doi: 10.1016/j.jtbi.2014.11.022. Epub 2014 Dec 4. Review.


Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.

Chaudhri G, Tahiliani V, Eldi P, Karupiah G.

J Virol. 2015 Feb;89(3):1889-99. doi: 10.1128/JVI.02572-14. Epub 2014 Nov 26.


Cytokine production associated with smallpox vaccine responses.

Simon WL, Salk HM, Ovsyannikova IG, Kennedy RB, Poland GA.

Immunotherapy. 2014;6(10):1097-112. doi: 10.2217/imt.14.72. Review.


Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Pugh C, Keasey S, Korman L, Pittman PR, Ulrich RG.

Clin Vaccine Immunol. 2014 Jun;21(6):877-85. doi: 10.1128/CVI.00035-14. Epub 2014 Apr 23.


Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.

Meseda CA, Campbell J, Kumar A, Garcia AD, Merchlinsky M, Weir JP.

PLoS One. 2013 Jun 13;8(6):e67984. doi: 10.1371/journal.pone.0067984. Print 2013.


Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review.

Elizaga ML, Vasan S, Marovich MA, Sato AH, Lawrence DN, Chaitman BR, Frey SE, Keefer MC; MVA Cardiac Safety Working Group.

PLoS One. 2013;8(1):e54407. doi: 10.1371/journal.pone.0054407. Epub 2013 Jan 17.


Genome-wide association study of antibody response to smallpox vaccine.

Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA.

Vaccine. 2012 Jun 13;30(28):4182-9. doi: 10.1016/j.vaccine.2012.04.055. Epub 2012 Apr 25.


Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Walsh SR, Dolin R.

Expert Rev Vaccines. 2011 Aug;10(8):1221-40. doi: 10.1586/erv.11.79. Review.


Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.

Dimier J, Ferrier-Rembert A, Pradeau-Aubreton K, Hebben M, Spehner D, Favier AL, Gratier D, Garin D, Crance JM, Drillien R.

J Virol. 2011 May;85(10):5016-26. doi: 10.1128/JVI.02359-10. Epub 2011 Mar 2.


VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.

Moise L, Buller RM, Schriewer J, Lee J, Frey SE, Weiner DB, Martin W, De Groot AS.

Vaccine. 2011 Jan 10;29(3):501-11. doi: 10.1016/j.vaccine.2010.10.064. Epub 2010 Nov 4.


Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.

Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R.

J Infect Dis. 2010 May 1;201(9):1353-60. doi: 10.1086/651560.


Smallpox vaccines for biodefense.

Kennedy RB, Ovsyannikova I, Poland GA.

Vaccine. 2009 Nov 5;27 Suppl 4:D73-9. doi: 10.1016/j.vaccine.2009.07.103. Review.


Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.

Johnson KL, Ovsyannikova IG, Mason CJ, Bergen HR 3rd, Poland GA.

Vaccine. 2009 Dec 10;28(1):38-47. doi: 10.1016/j.vaccine.2009.09.126. Epub 2009 Oct 12.

Supplemental Content

Support Center